NCT06416280

Brief Summary

The aim of the study isto evaluate the inter-observer reliability of the assessment of venous thromboembolic risk using the TRiP(cast) score in patients presenting with trauma to a lower limb requiring immobilisation, and of the clinicians' assessment using the physician's implicit probability (gestalt) compared with the use of the TRiP(cast) score.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
302

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 16, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

May 16, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

May 17, 2024

Status Verified

May 1, 2024

Enrollment Period

1 year

First QC Date

May 6, 2024

Last Update Submit

May 16, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • The primary aim is to assess the inter-observer reliability of venous thromboembolic risk assessment using the TRiP(cast) score in patients with lower limb trauma requiring immobilisation.

    Outcome measure : The rate of agreement or "concordance" will be estimated by the Kappa coefficient.

    Day 0

Interventions

In patients presenting to the emergency department with trauma to a lower limb, the TRiP(cast) score is assessed in accordance with the recommendations. If the patient does not object. The attending physician will then be asked to fill in his implicit assessment of the risk of venous thromboembolism on a paper CRF and then to complete his assessment of the TRiP(cast) score. He will then be free to decide whether or not to anticoagulate the patient. At the same time, a doctor not involved in the patient's care will assess the TRiP(cast) score and record it on a paper CRF. The second doctor's assessment will be independent and will have no impact on the patient's management. The CRFs will then be analysed and stored. Data will be anonymised during data collection and each patient will be assigned an anonymity number.

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Emergency department patients

You may qualify if:

  • Consultation in one of the emergency departments participating in the study,
  • Isolated trauma to a lower limb,
  • Rigid immobilisation (plaster or resin) or semi-rigid immobilisation for an expected duration of at least 7 days,
  • Patient over 18 years of age,
  • Patient affiliated to or benefiting from a social security scheme,
  • Patients who have signed a prior informed consent form

You may not qualify if:

  • Patient taking anticoagulant treatment at the time of the trauma,
  • Trauma requiring hospitalisation for more than 48 hours,
  • Pregnant, breast-feeding or parturient patients,
  • Patient deprived of liberty by judicial or administrative decision,
  • Patient under compulsory psychiatric care,
  • Patient under legal protection,
  • Patients unable to give their free and informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

DOUILLET Delphine

Angers, France

RECRUITING

MeSH Terms

Conditions

Venous ThromboembolismVenous ThrombosisPulmonary Embolism

Condition Hierarchy (Ancestors)

ThromboembolismEmbolism and ThrombosisVascular DiseasesCardiovascular DiseasesThrombosisLung DiseasesRespiratory Tract DiseasesEmbolism

Study Officials

  • Delphine DOUILLET

    University Hospital, Angers

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2024

First Posted

May 16, 2024

Study Start

May 16, 2024

Primary Completion

May 20, 2025

Study Completion

December 30, 2025

Last Updated

May 17, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations